Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Stark

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Frontiers in Oncology|July 18, 2022
Cancer, Fertility and Me: Developing and Testing a Novel Fertility Preservation Patient Decision Aid to Support Women at Risk of Losing Their Fertility Because of Cancer TreatmentGeorgina L Jones, Rachael H Moss, Frances Darby, et al.
Nature Biotechnology|April 29, 2020
Viral contamination in biologic manufacture and implications for emerging therapiesPaul W Barone, Michael E Wiebe, James C Leung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationThomas A Olson, Matthew J Murray, Carlos Rodriguez-Galindo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update ConsortiumJörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Lancet (London, England)|March 31, 2016
Cediranib in patients with relapsed platinum-sensitive ovarian cancer (ICON6): a randomised, double-blind, placebo-controlled phase 3 trialJonathan A Ledermann, Andrew C Embleton, Fharat Raja, et al.
Frontiers in Oncology|July 18, 2022
Cancer, Fertility and Me: Developing and Testing a Novel Fertility Preservation Patient Decision Aid to Support Women at Risk of Losing Their Fertility Because of Cancer TreatmentGeorgina L Jones, Rachael H Moss, Frances Darby, et al.
Nature Biotechnology|April 29, 2020
Viral contamination in biologic manufacture and implications for emerging therapiesPaul W Barone, Michael E Wiebe, James C Leung, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 26, 2015
Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to CollaborationThomas A Olson, Matthew J Murray, Carlos Rodriguez-Galindo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 17, 2021
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update ConsortiumJörg Beyer, Laurence Collette, Nicolas Sauvé, et al.
Pageof 4